UK earnings, trading statements calendar - next 7 days
17th Sep 2026 14:20
| Price | $0.97 on 21-09-2026 at 17:35:07 |
|---|---|
| Change | $0.00 0% |
| Buy | $0.972 |
| Sell | $0.966 |
| Last Trade: | Sell 1,332.00 at $0.97 |
| Day's Volume: | 3,155,206 |
| Last Close: | $0.97 |
| Open: | $0.972 |
| ISIN: | GB00BDGKMY29 |
| Day's Range | $0.966 - $0.972 |
| 52wk Range: | $0.876 - $1.00 |
| Market Capitalisation: | $1.09b |
| VWAP: | $0.969991 |
| Shares in Issue: | 1.12b |
Sector: Closed End Investments
Biopharma Cred. (BPCR) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 1,332 | $0.97 | Uncrossing Trade |
16:35:08 - 21-Sep-26 |
| Sell* | 36 | $0.966 | SI Trade |
16:29:28 - 21-Sep-26 |
| Buy* | 1,529 | $0.97 | Automatic Execution |
16:24:55 - 21-Sep-26 |
| Unknown* | 900 | $0.97 | OTC Trade |
16:10:14 - 21-Sep-26 |
| Sell* | 47 | $0.97 | Automatic Execution |
15:57:39 - 21-Sep-26 |
| Sell* | 19,940 | $0.97 | Automatic Execution |
15:57:39 - 21-Sep-26 |
| Sell* | 745 | $0.97 | Automatic Execution |
15:57:39 - 21-Sep-26 |
| Sell* | 19,904 | $0.97 | Automatic Execution |
15:57:39 - 21-Sep-26 |
| Buy* | 589 | $0.972 | Automatic Execution |
15:40:26 - 21-Sep-26 |
| Buy* | 411 | $0.972 | Automatic Execution |
15:40:26 - 21-Sep-26 |
Biopharma Cred. (BPCR) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 15th Sep 2026 1:03 pm | RNS | Directorate change |
| 3rd Sep 2026 3:08 pm | RNS-R | QuotedData's In The HotSeat |
| 26th Aug 2026 10:00 am | RNS | Notice of Half Year Results |
| 24th Aug 2026 4:00 pm | RNS | Net Asset Value(s) and Monthly Factsheet |
| 20th Aug 2026 7:00 am | RNS | Completion of Lumira Sale |
| 3rd Aug 2026 5:36 pm | RNS | Director/PDMR Shareholding |
| 3rd Aug 2026 5:14 pm | RNS | Director/PDMR Shareholding |
| 30th Jul 2026 4:00 pm | RNS | Net Asset Value(s) and Monthly Factsheet |
| 15th Jul 2026 7:00 am | RNS | NEW INVESTMENT IN KESTRA MEDICAL |
| 14th Jul 2026 7:00 am | RNS | UPDATE ON ARCHIMED ESPERION ACQUISITION |